CHD1L and breast cancer: Since it has been reported that patients with mesenchymal-like breast cancer had a worse outcome [30], [32], [33], our results in vitro somehow confirmed that CHD1L expression was related to an aggressive breast cancer biology and might also indicate the probability of CHD1L playing a role in EMT of breast cancer.